000 01340 a2200361 4500
005 20250514182757.0
264 0 _c20040506
008 200405s 0 0 eng d
022 _a0168-8510
024 7 _a10.1016/j.healthpol.2003.07.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLexchin, Joel
245 0 0 _aThe effect of generic competition on the price of brand-name drugs.
_h[electronic resource]
260 _bHealth policy (Amsterdam, Netherlands)
_cApr 2004
300 _a47-54 p.
_bdigital
500 _aPublication Type: Comparative Study; Evaluation Study; Journal Article
650 0 4 _aDrug Costs
_xstandards
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrug Prescriptions
_xclassification
650 0 4 _aDrugs, Generic
_xeconomics
650 0 4 _aEconomic Competition
650 0 4 _aFormularies as Topic
650 0 4 _aGovernment Programs
_xeconomics
650 0 4 _aHealth Services Research
650 0 4 _aHumans
650 0 4 _aInsurance, Pharmaceutical Services
_xeconomics
650 0 4 _aOntario
650 0 4 _aPatents as Topic
650 0 4 _aPrivate Sector
_xeconomics
650 0 4 _aPublic Sector
_xeconomics
773 0 _tHealth policy (Amsterdam, Netherlands)
_gvol. 68
_gno. 1
_gp. 47-54
856 4 0 _uhttps://doi.org/10.1016/j.healthpol.2003.07.007
_zAvailable from publisher's website
999 _c14751237
_d14751237